PNPLA3 and type 2 diabetes mellitus: As for the PNPLA3 I148M, lines of evidence have described the TM6SF2 E167K as a potential risk variant for T2D development,92, 93 mainly linked to increased hepatic and adipose insulin resistance and impaired pancreatic beta‐cell function.94